Lakewood-Amedex Biotherapeutics, Inc. ( LABT) - Stock Earnings
LABT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -744918 USD | — USD |
| 2026Q1 | -923291 USD | — USD |
| 2026Q2 | -3.8 million USD | — USD |
| 2026Q4 Est. | — | — |
LABT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.3 million USD | — USD |
| 2024 | -4.9 million USD | — USD |
| 2025 | -3.8 million USD | — USD |
| 2026 Est. | — | — |
LABT
Price: $0.59
52 week price:
Earnings Per Share: -2.41 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 million